| Mrs Sarah Rae Viola, MA, OTR/L | |
|
707 Taylor Dr, Aberdeen, SD 57401-6863 | |
| (701) 830-0390 | |
| Not Available |
| Full Name | Mrs Sarah Rae Viola |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 14 Years |
| Location | 707 Taylor Dr, Aberdeen, South Dakota |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063021756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XG0600X | Occupational Therapist - Gerontology | 1060 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brain Intercept Inc | 3476960519 | 2 |
News Archive
Mylan Inc. and the Canadian AIDS Society (CAS) today announced a joint initiative to raise funds and awareness for Canadians and people worldwide who are living with or at risk of HIV/AIDS.
Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival.
Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.
› Verified 7 days ago
| Provider Name | Brain Intercept Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881296861 PECOS PAC ID: 3476960519 Enrollment ID: O20210407002186 |
News Archive
Mylan Inc. and the Canadian AIDS Society (CAS) today announced a joint initiative to raise funds and awareness for Canadians and people worldwide who are living with or at risk of HIV/AIDS.
Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival.
Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah Rae Viola, MA, OTR/L 707 Taylor Dr, Aberdeen, SD 57401-6863 Ph: (701) 830-0390 | Mrs Sarah Rae Viola, MA, OTR/L 707 Taylor Dr, Aberdeen, SD 57401-6863 Ph: (701) 830-0390 |
News Archive
Mylan Inc. and the Canadian AIDS Society (CAS) today announced a joint initiative to raise funds and awareness for Canadians and people worldwide who are living with or at risk of HIV/AIDS.
Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival.
Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.
› Verified 7 days ago
Heather L Thorson, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 Fax: 605-622-5255 | |
David Rasmusson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 Fax: 605-622-5255 | |
Sunny Lester, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 618 Kettering Dr, Aberdeen, SD 57401 Phone: 605-225-7044 | |
Shauna Larson, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S Kline St, Aberdeen, SD 57401 Phone: 605-228-5454 | |
Christa M Weber, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 805 1st Ave Se, Aberdeen, SD 57401 Phone: 605-622-5878 Fax: 605-622-5888 | |
Dalita L Meyer, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 Fax: 605-622-5255 |